SCHEMBL6175217

SCHEMBL6175217

CC(c1ccncc1NC(=O)c1ccc(Cl)cc1)C1(C(C)c2ccncc2NC(=O)c2ccc(Cl)cc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
LMNA P02545 2/20 0.42
ALDH1A1 P00352 1/20 0.40
F10 P00742 1/20 0.40
NAMPT P43490 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GCGR P47871 4/20 0.37
ABL1 P00519 3/20 0.37
LIPE Q05469 1/20 0.37
HSD17B13 Q7Z5P4 1/20 0.37
MAPT P10636 1/20 0.37
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172977 0.93 CYP3A4 (0.43) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6174515 0.92 ALDH1A1 (0.45) GAACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL6174642 0.91 ALDH1A1 (0.42) GAACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL6173454 0.88 CYP2C9 (0.41) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6174469 0.88 TDP1 (0.42) GAACYP3A4CYP2C9CYP2C19ALDH1A1
SCHEMBL6173988 0.87 LMNA (0.42) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6172844 0.87 CYP3A4 (0.40) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6173479 0.84 ALDH1A1 (0.44) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6174412 0.84 MAPT (0.39) GAACYP3A4CYP2C9CYP2C19LMNA
SCHEMBL6175907 0.83 ALDH1A1 (0.39) GAACYP3A4CYP2C9CYP2C19LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed